Related Experiment Videos
Clinical stage B prostate carcinoma: staging with MR imaging
Radiology
|February 1, 1987
Summary
Magnetic resonance (MR) imaging shows promise for staging prostate cancer. This study found MR imaging accurately differentiates between stage B and more advanced prostate cancer stages.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Accurate staging of prostate cancer is crucial for effective treatment planning.
- Distinguishing between clinical stage B and more advanced stages (C/D) impacts therapeutic decisions.
Purpose of the Study:
- To evaluate the efficacy of Magnetic Resonance (MR) imaging in staging prostate cancer.
- To correlate MR imaging findings with surgical and pathological results for accuracy assessment.
Main Methods:
- MR imaging, including T1 and T2-weighted spin echo sequences, was performed on 29 patients with stage B prostate cancer.
- Imaging findings were correlated with surgical/pathologic outcomes in 18 patients.
- Assessment focused on periprostatic fat, venous plexus, seminal vesicles, and lymph nodes.
Main Results:
- MR imaging demonstrated high accuracy in detecting extracapsular extension and seminal vesicular involvement.
- Individually, periprostatic fat signal had 100% specificity for extracapsular extension.
- When considering all assessed features, MR imaging achieved 89% accuracy in differentiating stage B from stages C/D disease.
Conclusions:
- MR imaging is a valuable and promising tool for accurate prostate cancer staging.
- The comprehensive assessment of specific anatomical features on MR imaging enhances staging accuracy.
- Further research can validate MR imaging's role in routine clinical practice for prostate cancer management.